i) The drug-protein interaction network
ii) The table result of interaction with GINS3_Q9BRX5
| Protein | Type | Gene Name | Drug | Drug Source | R | FDR | Cancer | |
|---|---|---|---|---|---|---|---|---|
 |
GINS3_Q9BRX5 | Canonical | GINS3 | vinblastine | GDSC1:1004 | -0.179 | 7.019e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | methotrexate | GDSC1:1008 | -0.224 | 5.324e-04 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | olaparib | GDSC1:1017 | 0.14 | 4.229e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | AZD7762 | GDSC1:1022 | -0.283 | 6.979e-06 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | afatinib | GDSC1:1032 | 0.138 | 4.509e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | bortezomib | GDSC1:104 | -0.138 | 4.582e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | NVP-BEZ235 | GDSC1:1057 | -0.223 | 5.569e-04 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | GDC-0941 | GDSC1:1058 | -0.137 | 4.680e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | ERK5-IN-1 | GDSC1:106 | 0.157 | 1.983e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | paclitaxel | GDSC1:11 | -0.167 | 1.290e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | CYC-202 | GDSC1:110 | 0.174 | 9.340e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | salubrinal | GDSC1:111 | 0.136 | 4.909e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | TW-37 | GDSC1:1149 | -0.199 | 2.476e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | QL-XII-61 | GDSC1:1203 | 0.138 | 4.573e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | JQ1-(+) | + | -0.164 | 1.459e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | PFI-1 | GDSC1:1219 | 0.137 | 4.656e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | camptothecin | GDSC1:1494 | -0.205 | 1.714e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | GDC-0941 | GDSC1:1527 | -0.139 | 4.292e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | pevonedistat | GDSC1:1529 | -0.18 | 6.754e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | SB-715992 | GDSC1:208 | -0.228 | 4.112e-04 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | TAK-715 | GDSC1:221 | 0.188 | 4.520e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | Akti-1/2 | GDSC1:228 | 0.141 | 4.051e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | enzastaurin | GDSC1:229 | 0.161 | 1.685e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | idelalisib | GDSC1:238 | 0.154 | 2.321e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | cabozantinib | GDSC1:249 | 0.154 | 2.318e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | WZ3105 | GDSC1:252 | -0.143 | 3.662e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | XMD14-99 | GDSC1:253 | 0.15 | 2.727e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | NPK76-II-72-1 | GDSC1:257 | 0.176 | 8.287e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | tubastatin-A | GDSC1:265 | 0.247 | 1.079e-04 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | AR-42 | GDSC1:272 | -0.189 | 4.120e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | CUDC-101 | GDSC1:273 | -0.163 | 1.563e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | belinostat | GDSC1:274 | -0.197 | 2.763e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | I-BET-762 | GDSC1:275 | 0.144 | 3.498e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | CAY10603 | GDSC1:276 | -0.279 | 9.708e-06 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | BIX 02189 | GDSC1:279 | 0.156 | 2.154e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | GSK-2126458 | GDSC1:283 | -0.222 | 6.216e-04 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | Bayer IKKb inhibitor | GDSC1:290 | 0.226 | 4.567e-04 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | OSI-930 | GDSC1:298 | 0.179 | 7.014e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | WY-090217 | GDSC1:3 | -0.167 | 1.288e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | PI-103 | GDSC1:302 | -0.169 | 1.153e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | Y-39983 | GDSC1:309 | 0.147 | 3.097e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | YM-201636 | GDSC1:310 | 0.143 | 3.705e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | WYE-125132 | GDSC1:317 | -0.242 | 1.545e-04 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | tozasertib | GDSC1:32 | -0.153 | 2.379e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | SNX-2112 | GDSC1:328 | -0.162 | 1.589e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | QL-XI-92 | GDSC1:329 | 0.222 | 5.877e-04 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | XMD13-2 | GDSC1:330 | 0.16 | 1.781e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | CI-1033 | GDSC1:362 | -0.15 | 2.768e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | Torin 2 | GDSC1:371 | -0.151 | 2.586e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | Brivanib | GDSC1:376 | 0.146 | 3.306e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | GDC0980 | GDSC1:382 | -0.14 | 4.201e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | venetoclax | GDSC1:412 | -0.179 | 7.197e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | 9-??-D-Arabinofuranosyl guanine | GDSC1:427 | 0.173 | 9.738e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | NSC319726 | GDSC1:461 | -0.162 | 1.652e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | ARRY-520 | GDSC1:474 | -0.178 | 7.526e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | LDN-193189 | GDSC1:478 | -0.139 | 4.292e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | CGP-60474 | GDSC1:53 | -0.182 | 6.185e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | CINK4 | GDSC1:54 | 0.2 | 2.230e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | BI-2536 | GDSC1:60 | -0.203 | 1.870e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | JW-7-52-1 | GDSC1:83 | -0.151 | 2.663e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | KIN001-139 | GDSC1:86 | -0.183 | 5.859e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | GW-843682X | GDSC1:87 | -0.211 | 1.212e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | MG-132 | GDSC1:9 | -0.148 | 2.943e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | camptothecin | GDSC2:1003 | -0.201 | 2.191e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | vinblastine | GDSC2:1004 | -0.196 | 2.896e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | cisplatin | GDSC2:1005 | 0.145 | 3.409e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | afatinib | GDSC2:1032 | 0.146 | 3.227e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | Wee1 Inhibitor | GDSC2:1046 | 0.145 | 3.450e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | mirin | GDSC2:1048 | 0.144 | 3.520e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | NVP-BEZ235 | GDSC2:1057 | -0.163 | 1.550e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | 5-fluorouracil | GDSC2:1073 | 0.181 | 6.347e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | sorafenib | GDSC2:1085 | 0.188 | 4.475e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | BI-2536 | GDSC2:1086 | -0.166 | 1.330e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | irinotecan | GDSC2:1088 | 0.16 | 1.792e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | oxaliplatin | GDSC2:1089 | 0.169 | 1.152e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | bortezomib | GDSC2:1191 | -0.138 | 4.438e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | BMS-345541 | GDSC2:1249 | 0.157 | 2.011e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | I-BET-762 | GDSC2:1624 | 0.23 | 3.612e-04 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | oxaliplatin | GDSC2:1806 | 0.225 | 5.013e-04 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | teniposide | GDSC2:1809 | -0.138 | 4.565e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | dactinomycin | GDSC2:1811 | -0.154 | 2.294e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | nelarabine | GDSC2:1814 | 0.14 | 4.151e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | Podophyllotoxin bromide | GDSC2:1825 | -0.167 | 1.260e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | BI-97C1 | GDSC2:1849 | -0.158 | 1.909e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | dactinomycin | GDSC2:1911 | -0.157 | 1.984e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | I-BRD9 | GDSC2:1928 | 0.179 | 7.167e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | MIRA-1 | GDSC2:1931 | 0.14 | 4.151e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | MIM-1 | GDSC2:1996 | 0.162 | 1.647e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | Pyridostatin | GDSC2:2044 | 0.148 | 3.046e-02 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | vinorelbine | GDSC2:2048 | -0.199 | 2.476e-03 | ALL |
|
GINS3_Q9BRX5 | Canonical | GINS3 | VE 821 | GDSC2:2111 | 0.139 | 4.296e-02 | ALL |
